I am BIO Podcast: Hope for Alzheimer’s
In her latest I am BIO Podcast, BIO President and CEO Dr. Michelle McMurry-Heath speaks with three guests who are fighting to bend the […]
I am BIO Podcast: Hope for Alzheimer’s Read More »
In her latest I am BIO Podcast, BIO President and CEO Dr. Michelle McMurry-Heath speaks with three guests who are fighting to bend the […]
I am BIO Podcast: Hope for Alzheimer’s Read More »
Certain serious psychiatric or gastrointestinal conditions require neuroleptic drugs, which are designed to block dopamine receptors in the brain and central nervous system, but
Awareness of tardive dyskinesia is the best defense Read More »
A man in Colorado tested positive for an H5 bird flu virus, marking the first recorded human infection in the United States of the
First U.S. case of human infected with bird flu reported in Colorado Read More »
In the United States, over 500 people lose a limb daily, the Amputee Coalition says, adding that the number of people living with limb
National Limb Loss and Limb Difference Awareness Month highlights risks and challenges Read More »
Today on the House floor, U.S. Rep. Nanette Diaz Barragán (D-CA) spoke out against the recent Centers for Medicare and Medicaid Services (CMS) decision
Rep. Barragán: CMS Alzheimer’s drug decision is ‘a mistake’ Read More »
The Lyme disease vaccine candidate developed by Pfizer and Valneva was “found to be more immunogenic” in pediatric patients than in adults in a
Pfizer-Valneva Lyme vaccine shows promising results in children Read More »
While Parkinson’s disease is still incurable, biotechnology, supported by good policy, offers the promise of better treatments, and perhaps an eventual cure. This is
Parkinson’s Awareness Month highlights hope of progress through research Read More »
Does the U.S. Food and Drug Administration (FDA) question the decision by the Centers for Medicaid and Medicare Services (CMS) to limit coverage of
Does the FDA question the Aduhelm decision? Read More »
The U.S. Food and Drug Administration (FDA) on Monday said it has expanded approval for Gilead Sciences Inc.’s Veklury (remdesivir) to include pediatric patients
Veklury becomes first FDA-approved COVID treatment for children under 12 Read More »
Nkarta today announced positive preliminary data in two Phase 1 clinical trials of its natural killer cell therapies to treat patients with advanced blood
Nkarta announces positive preliminary results with natural killer cell cancer therapies Read More »